Literature DB >> 564799

Characterization of seven C-peptide antisera.

O K Faber, C Binder, J Markussen, L G Heding, V K Naithani, H Kuzuya, P Blix, D L Horwitz, A H Rubenstein.   

Abstract

The plasma C-peptide immunoreactivity (CPR) in 10 normal subjects varied considerably when measured with different antisera in parallel assays. The CPR level correlated with the blank "CPR" value measured in plasma devoid of C-peptide and to a lesser degree with the sensitivity of the standard curves obtained with the individual antisera. Storage of plasma samples at different temperatures and for different lengths of time before the analyses were carried out resulted in further variation in the CPR results. This was caused by a time- and temperature-dependent fall in CPR, which was more pronounced with some antisera than with others. This sensitivity to storage of plasma did not correlate with the antigenic characteristics of the antisera as determined by their reactivity with 11 specific fragments of the C-peptide molecule. The contribution of human proinsulin to the CPR concentration relative in normal subjects was considered to be negligible even though the relative immunoreactivity of human proinsulin and C-peptide ranged from 11 to 143 per cent among these antisera. These results suggest that differences in C-peptide antisera are a major reason for the variation in the concentration of circulating CPR as measured in different C-peptide immunoassays.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 564799     DOI: 10.2337/diab.27.1.s170

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  70 in total

1.  The effect of genetically engineered glucagon on glucose recovery after hypoglycaemia in man.

Authors:  A Hvidberg; S Jørgensen; J Hilsted
Journal:  Br J Clin Pharmacol       Date:  1992-12       Impact factor: 4.335

2.  Onset features and subsequent clinical evolution of childhood diabetes over several years.

Authors:  Rebecca B Lipton; Melinda L Drum; Kirstie K Danielson; Siri Aw Greeley; Graeme I Bell; William A Hagopian
Journal:  Pediatr Diabetes       Date:  2011-03-23       Impact factor: 4.866

3.  Quantitative and qualitative differences in basal and glucose- and arginine-stimulated insulin secretion in healthy subjects and different stages of NIDDM.

Authors:  K Ratheiser; W Reitgruber; M Komjati; P Bratusch-Marrain; H Vierhapper; W K Waldhäusl
Journal:  Acta Diabetol Lat       Date:  1990 Jul-Sep

4.  Abnormalities in the ultradian oscillations of insulin secretion and glucose levels in type 2 (non-insulin-dependent) diabetic patients.

Authors:  J Sturis; K S Polonsky; E T Shapiro; J D Blackman; N M O'Meara; E van Cauter
Journal:  Diabetologia       Date:  1992-07       Impact factor: 10.122

5.  Factors affecting fasting serum C-peptide levels in Micronesians: comparison with a Caucasoid population.

Authors:  P Garcia-Webb; P Zimmet; A Bonser; H King; S Bottomley
Journal:  Diabetologia       Date:  1984-07       Impact factor: 10.122

6.  Severe insulin-resistant diabetes mellitus in patients with congenital muscle fiber type disproportion myopathy.

Authors:  H Vestergaard; H H Klein; T Hansen; J Müller; F Skovby; C Bjørbaek; M E Røder; O Pedersen
Journal:  J Clin Invest       Date:  1995-04       Impact factor: 14.808

7.  24-hour glucose profiles during continuous or oscillatory insulin infusion. Demonstration of the functional significance of ultradian insulin oscillations.

Authors:  J Sturis; A J Scheen; R Leproult; K S Polonsky; E van Cauter
Journal:  J Clin Invest       Date:  1995-04       Impact factor: 14.808

8.  Defective glucose counterregulation after subcutaneous insulin in noninsulin-dependent diabetes mellitus. Paradoxical suppression of glucose utilization and lack of compensatory increase in glucose production, roles of insulin resistance, abnormal neuroendocrine responses, and islet paracrine interactions.

Authors:  G B Bolli; E Tsalikian; M W Haymond; P E Cryer; J E Gerich
Journal:  J Clin Invest       Date:  1984-06       Impact factor: 14.808

9.  Studies on overnight insulin requirements and metabolic clearance rate of insulin in normal and diabetic man: relevance to the pathogenesis of the dawn phenomenon.

Authors:  P De Feo; G Perriello; M M Ventura; F Calcinaro; G Basta; C Lolli; C Cruciani; A Dell'Olio; F Santeusanio; P Brunetti
Journal:  Diabetologia       Date:  1986-08       Impact factor: 10.122

10.  Fasting plasma C-peptide, glucagon stimulated plasma C-peptide, and urinary C-peptide in relation to clinical type of diabetes.

Authors:  H J Gjessing; L E Matzen; O K Faber; A Frøland
Journal:  Diabetologia       Date:  1989-05       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.